Loading...
White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation
Body fluid biomarkers have great potential for different clinical purposes, including diagnosis, prognosis, patient stratification and treatment effect monitoring. This is exemplified by current use of several excellent biomarkers, such as the Alzheimer’s disease cerebrospinal fluid (CSF) biomarkers...
Na minha lista:
| Udgivet i: | Alzheimers Res Ther |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5855933/ https://ncbi.nlm.nih.gov/pubmed/29544527 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-018-0359-x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|